Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Culture Change At GSK: 'We’re Doing What We Said We’d Do'
R&D Chief Says Doubters Are Coming Round
Oct 09 2019
•
By
Andrew McConaghie
GSK is adopting 'smart risk taking' in R&D • Source: GSK
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Immuno-oncology
More from Anticancer